Atara Biotherapeutics (NASDAQ:ATRA) has announced plans to cut around 50% of its workforce, just a little over a week after it said the FDA had declined to approve its immunotherapy Ebvallo.

They’re one of those products everyone has in their bathroom cupboard - and whether man or woman, you’ve probably bought at least one pack of razors in your lifetime. Whether the cheapy ...